Savanna Jean Lee, | |
600 Ne Adams Dairy Pkwy Ste 200, Blue Springs, MO 64014-5495 | |
(816) 347-4600 | |
Not Available |
Full Name | Savanna Jean Lee |
---|---|
Gender | Female |
Speciality | Family Medicine |
Location | 600 Ne Adams Dairy Pkwy Ste 200, Blue Springs, Missouri |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1770043242 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 2023010970 (Missouri) | Primary |
Entity Name | Saint Lukes Physician Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093263717 PECOS PAC ID: 3577476894 Enrollment ID: O20031111000818 |
News Archive
York University researchers say a simple test that combines thinking and movement can help to detect heightened risk for developing Alzheimer's disease in a person, even before there are any telltale behavioural signs of dementia.
A new study being published in the journal Urology shows that Proantinox, a proprietary cranberry-based blend used successfully in hospitals and long-term care facilities as UTI-Stat, and now available directly to consumers as new Cystex Liquid Cranberry Complex with Proantinox, is safe and effective in significantly reducing the incidence of UTIs in women at risk for recurring infections.
The Swedish MedTech company Lumito is at its final stages of developing a new and unique method for digital tissue diagnostics that streamlines diagnosis and improves accuracy.
Researchers have been seeking a safe and effective way to treat cognitive impairments associated with schizophrenia by enhancing N-methyl-D-aspartate (NMDA) glutamate receptors. Functional deficits in NMDA receptors may contribute to the underlying neurobiology of this disorder.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has requested and been granted a Type B pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding its RIGSĀ® technology Biologic License Application (BLA). The pre-IND meeting request is another step in Neoprobe's efforts to develop and commercialize the RIGS technology designed to enhance the surgical treatment of patients with solid tumor cancers.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Savanna Jean Lee, 600 Ne Adams Dairy Pkwy Ste 200, Blue Springs, MO 64014-5495 Ph: (816) 347-4600 | Savanna Jean Lee, 600 Ne Adams Dairy Pkwy Ste 200, Blue Springs, MO 64014-5495 Ph: (816) 347-4600 |
News Archive
York University researchers say a simple test that combines thinking and movement can help to detect heightened risk for developing Alzheimer's disease in a person, even before there are any telltale behavioural signs of dementia.
A new study being published in the journal Urology shows that Proantinox, a proprietary cranberry-based blend used successfully in hospitals and long-term care facilities as UTI-Stat, and now available directly to consumers as new Cystex Liquid Cranberry Complex with Proantinox, is safe and effective in significantly reducing the incidence of UTIs in women at risk for recurring infections.
The Swedish MedTech company Lumito is at its final stages of developing a new and unique method for digital tissue diagnostics that streamlines diagnosis and improves accuracy.
Researchers have been seeking a safe and effective way to treat cognitive impairments associated with schizophrenia by enhancing N-methyl-D-aspartate (NMDA) glutamate receptors. Functional deficits in NMDA receptors may contribute to the underlying neurobiology of this disorder.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has requested and been granted a Type B pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding its RIGSĀ® technology Biologic License Application (BLA). The pre-IND meeting request is another step in Neoprobe's efforts to develop and commercialize the RIGS technology designed to enhance the surgical treatment of patients with solid tumor cancers.
› Verified 2 days ago
Bruce R Williams, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1509 Nw Mock Ave, Blue Springs, MO 64015 Phone: 816-229-8187 Fax: 816-229-1181 | |
Dr. Joseph T. Mackey, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 104 No. 7 Highway, Suite B, Blue Springs, MO 64014 Phone: 816-229-8880 Fax: 816-229-4363 | |
Russell Jay Thornton, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 Nw Mock Ave, Blue Springs, MO 64015 Phone: 816-224-0400 Fax: 816-224-0418 | |
Kandice L. Fleming, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 725 Nw State Route 7 Ste B, Blue Springs, MO 64014 Phone: 816-229-8187 Fax: 816-229-0376 | |
Dr. Leigh Gilburn, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5435 Sw Us Highway 40, Blue Springs, MO 64015 Phone: 816-745-7288 | |
Dr. Theresa C Garcia, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1416 Nw State Route 7, Blue Springs, MO 64014 Phone: 816-427-5320 Fax: 888-807-2718 | |
Dr. John E. Peterson, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 104 N 7 Highway, Suite B, Blue Springs, MO 64014 Phone: 816-229-8880 Fax: 816-229-4363 |